CIS-RESORCYLIDE, PHARMACEUTICAL COMPOSITION CONTAINING IT, USE THEREOF IN THE TREATMENT OF THROMBOSIS AND RELATED DISORDERS

A compound that is useful for inhibiting FXIIIa catalysis of fibrin cross-linking, and related pharmaceutical compositions and methods, are disclosed. The compound and compositions may be advantageously used to enhance fibrinolysis and resolution of blood clots. Composé apte à inhiber la catalyse pa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MARTINEZ, THERESA, RASSING, BIRGITTE, ROEMER, FRANKLIN, HANK, R, BISHOP, PAUL, D, WEST, ROBERT, R
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A compound that is useful for inhibiting FXIIIa catalysis of fibrin cross-linking, and related pharmaceutical compositions and methods, are disclosed. The compound and compositions may be advantageously used to enhance fibrinolysis and resolution of blood clots. Composé apte à inhiber la catalyse par FXIIIa de la réticulation de fibrine, et compositions et procédés pharmaceutiques associés. Ledit composé et lesdites compositions peuvent avantageusement servir à favoriser la fibrinolyse et la décomposition des caillots sanguins.